Genesis Therapeutics Secures $52M Series A to Further Accelerate AI Innovation and to Launch Drug Discovery & Development Pipeline
The Pharma Data
DECEMBER 1, 2020
Rowe Price Associates, Inc., In our diligence process, we were impressed not only by the rigor of their platform and the extensive AI and drug development accomplishments of their team, but also by the nascent yet powerful applications of their platform to laboratory experiments for their drug discovery pipeline.
Let's personalize your content